Theodoros Karampatakis, Katerina Tsergouli, Eleni Kandilioti, Anna Nikopoulou, Helen Katsifa, Melina Kachrimanidou
{"title":"Implication of COVID-19 pandemic on the incidence of <i>Clostridioides difficile</i> infection in a Greek tertiary hospital.","authors":"Theodoros Karampatakis, Katerina Tsergouli, Eleni Kandilioti, Anna Nikopoulou, Helen Katsifa, Melina Kachrimanidou","doi":"10.1099/jmm.0.001689","DOIUrl":null,"url":null,"abstract":"<p><p><b>Introduction.</b> <i>C. difficile</i> infection (CDI) represents an important global threat. In the COVID-19 era, the multifactorial nature of CDI has emerged.<b>Hypothesis - Aim.</b> The aim was to assess the impact of COVID-19 pandemic on the incidence of CDI in a Greek hospital.<b>Methodology.</b> A retrospective study was performed throughout a 51 month period (January 2018 to March 2022), divided into two periods: pre-pandemic (January 2018 to February 2020) and COVID-19 pandemic (March 2020 to March 2022). The effects of the pandemic compared to the pre-pandemic period on the incidence of CDI [expressed as infections per 10 000 bed days (IBD)] were studied using interrupted time-series analysis.<b>Results.</b> Throughout the study, there was an increase in the monthly CDI incidence from 0.00 to 11.77 IBD (<i>P</i><0.001). Interrupted time-series disclosed an increase in CDI incidence during the pre-pandemic period from 0.00 to 3.36 IBD (<i>P</i><0.001). During the COVID-19 pandemic period the linear trend for monthly CDI rose from 2.65 to 13.93 IBD (<i>P</i><0.001). The increase rate was higher during the COVID-19 pandemic period (r<sub>2</sub> = +0.47) compared to the pre-pandemic period (r<sub>1</sub> = +0.16).<b>Conclusion.</b> A significant increase of CDI incidence was observed, with the rate of the rise being more intense during the COVID-19 pandemic.</p>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":"72 5","pages":""},"PeriodicalIF":4.6000,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1099/jmm.0.001689","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction.C. difficile infection (CDI) represents an important global threat. In the COVID-19 era, the multifactorial nature of CDI has emerged.Hypothesis - Aim. The aim was to assess the impact of COVID-19 pandemic on the incidence of CDI in a Greek hospital.Methodology. A retrospective study was performed throughout a 51 month period (January 2018 to March 2022), divided into two periods: pre-pandemic (January 2018 to February 2020) and COVID-19 pandemic (March 2020 to March 2022). The effects of the pandemic compared to the pre-pandemic period on the incidence of CDI [expressed as infections per 10 000 bed days (IBD)] were studied using interrupted time-series analysis.Results. Throughout the study, there was an increase in the monthly CDI incidence from 0.00 to 11.77 IBD (P<0.001). Interrupted time-series disclosed an increase in CDI incidence during the pre-pandemic period from 0.00 to 3.36 IBD (P<0.001). During the COVID-19 pandemic period the linear trend for monthly CDI rose from 2.65 to 13.93 IBD (P<0.001). The increase rate was higher during the COVID-19 pandemic period (r2 = +0.47) compared to the pre-pandemic period (r1 = +0.16).Conclusion. A significant increase of CDI incidence was observed, with the rate of the rise being more intense during the COVID-19 pandemic.